The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Kropz gets more cash; Audioboom releases new podcasts

Thu, 01st Sep 2022 21:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Open Orphan PLC - London-based pharmaceutical services - Its clinical laboratories in Queen Mary's Bioenterprise Centre and Plumbers Row wins accreditation by the College of American Pathologists. "The company sought the accreditation as part of its ongoing commitment to maintaining best in class quality systems," it explains.

----------

Audioboom Group PLC - London-based podcast producer - Expands its podcast network with the launch of three new shows from Audioboom Studios, the company's production arm. "Audioboom's continued investment into content development will further grow the company's intellectual property, deliver increased gross margins to the business, expand audience reach, and develop premium advertising inventory," it says. Launches 'Glittering A Turd' from Kris Hallenga, 'Killers, Cults and Queens' from Cheryl Hole and Nikki Druce, and 'Superpower State of Mind' from Malin Andersson.

----------

Sopheon PLC - Minnesota, US-based enterprise software provider - Updates management product Accolade. "Using Accolade, Sopheon's long-standing blue-chip customers across a diverse range of industries have experienced superior strategy-to-execution performance, reduced time-to-market, improved efficiency, and greater product success rate," it explains.

----------

Cloudbreak Discovery PLC - Vancouver, Canada-based natural resource project generator - Draws down GBP180,000 of the GBP10 million equity drawdown agreement with Crescita Capital LLC, which was originally entered into in February 2021. Shares issued at 1.5 pence each, seeing 12 million new shares issued. "The capital drawn down will be used to advance the company's acquisitions of energy royalties, lithium assets and bauxite projects globally," it explains.

----------

Power Metal Resources PLC - metals exploration company focused on North America, Africa and Australia - Wholly owned Australian subsidiary Power Metal Resources Australia sees confirmation of grant of exploration licence application 2021-000163, covering 999 square kilometres of ground in the Anna Creek area of South Australia. Exploration licence will last for 6 years, ending August 2028, and subject to minimum spend of AUD100,000, about GBP59,000. Chief Executive Paul Johnson says: "There is more work to do, clearly, and we are early stage here, however all projects of substance start early stage and the Wilan Project is off to a great start."

----------

Kropz PLC - African phosphate developer - Draws down ZAR47 million from recent bridge loan facility of ZAR121.5 million with major shareholder, the ARC Fund, to meet immediate cash requirements due to further delays in the ramp up of operations at Kropz Elandsfontein Ltd. "Progress continues to be made, however, in the ramp up," it adds. "Kropz and ARC Fund are currently working on a comprehensive funding structure to finance any further funding requirements in Kropz."

----------

Hummingbird Resources PLC - gold production, development and exploration focused on West Africa - Says development and construction of its second gold mine, Kouroussa, is now over 50% completed and remains on time and budget to achieve first gold pour by the end of the second quarter of 2023, which will more than double Hummingbird's gold production profile. Notes final assay results confirmed, with results showing 9.0 metres at 32.60 grammes per tonne gold from 116 metres.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Nov 2019 16:29

Open Orphan inks preferred partner deal with Ipsen Group

(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform Open Orphan announced the signing of a preferred partner agreement with Ipsen Group on Monday.

Read more
11 Nov 2019 13:48

Open Orphan Inks Venn Life Preferred Partner Agreement With Ipsen

Open Orphan Inks Venn Life Preferred Partner Agreement With Ipsen

Read more
15 Oct 2019 13:11

Open Orphan Inks Health Data Platform Deal With Empiric Logic

Open Orphan Inks Health Data Platform Deal With Empiric Logic

Read more
15 Oct 2019 11:13

Open Orphan signs deal with Empiric Logic to complete Health Data platform

(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform provider Open Orphan has signed a new strategic collaboration agreement with Empiric Logic, it announced on Tuesday, to build on the earlier work it had performed, and complete the build out of its 'Health Data' platform as Europe's first rare disease, advocacy-led genomic database.

Read more
25 Sep 2019 11:51

Open Orphan Loss Widens On Venn Life Sciences Combination Cost

Open Orphan Loss Widens On Venn Life Sciences Combination Cost

Read more
1 Aug 2019 17:37

Open Orphan Names Ex-Horizon Therapeutics Director As Non-Executive

(Alliance News) - Drug consulting platform Open Orphan PLC said on Thursday that it has appointed David Kelly as an independent non-executive director.Kelly, the company said, has orphan in

Read more
12 Jul 2019 11:57

Open Orphan Divests Remaining 3.1% Stake In Integumen

(Alliance News) - Open Orphan PLC has netted over GBP500,000 after selling the rest of its shares in skin-care firm Integumen PLC, Open Orphan said on Friday.The sale of the 30.1 million on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.